Bridging Clinical Practice and Drug Development, Ora Appoints Dr. John Trein as Therapeutic Lead, Posterior

by Business Wire • 2026/08/18 • 0 Comments

BOSTON--(BUSINESS WIRE)-- #ClinicalResearch--Ora, the world's leading ophthalmic contract research organization, appoints retina specialist Dr. John Trein as Therapeutic Lead, Posterior

← Stuart Therapeutics, Inc. Appoints David Jakeman as Chief Financial Officer

Tirzepatide may not raise risk for diabetic retinopathy →

Post navigation